Literature DB >> 24008935

[High performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism].

Esther Rojo-Martinez1, María Sandín-Fuentes, Ana I Calleja-Sanz, Elisa Cortijo-García, Pablo García-Bermejo, Marina Ruiz-Piñero, Jerónimo Rubio-Sanz, Juan F Arenillas-Lara.   

Abstract

INTRODUCTION: Implantable loop recorders (ILR) may allow detection of occult paroxysmal atrial fibrillation (PAF) in patients with cryptogenic ischemic stroke. However, optimal selection algorithm and ideal duration of monitoring remain unclear. AIM. To determine the incidence and time-profile of PAF in patients with cryptogenic ischemic stroke studied with Reveal XT ILR, who were selected based on a high suspicion of cerebral embolism. SELECTION CRITERIA: absence of stroke etiology after complete study including vascular imaging, transesophageal echocardiography and at least 24 hours of cardiac rhythm monitoring, and confirmation of acute embolic occlusion of intracranial artery by transcranial duplex or characteristics of acute ischemic lesion on neuroimaging suggesting embolic mechanism of ischemia. After implanting Reveal XT ILR, patients were trained to perform transmissions monthly or when symptoms occurred. We reviewed the information online each month and patients underwent clinical visits at 3rd and 6th month and then every six months.
RESULTS: We included 101 patients with cryptogenic ischemic stroke and at least one month of follow-up after ILR implant. Mean age was 67 years, 54 women (53.5%). Mean follow-up after implantation was 281 ± 212 days. Occult PAF was detected in 34 patients (33.7%). Frequency of false positives: 22.8%. Median time from implant to arrhythmia detection was 102 days (range: 26-240 days). 24 (70%) patients with PAF had several arrhythmic episodes detected with ILR. The majority of events (75%) were detected during the first six months of monitoring.
CONCLUSIONS: In our patients with probably embolic cryptogenic ischemic stroke, PAF was detected by Reveal XT ILR in 33.7%. One in four events occurred after the first six months of monitoring.

Entities:  

Mesh:

Year:  2013        PMID: 24008935

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  18 in total

Review 1.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

2.  Cryptogenic stroke: A diagnostic challenge.

Authors:  Shadi Yaghi; Mitchell S V Elkind
Journal:  Neurol Clin Pract       Date:  2014-10

Review 3.  Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact.

Authors:  Polychronis E Dilaveris; Harold L Kennedy
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

4.  Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study.

Authors:  Sergio Conti; James A Reiffel; Bernard J Gersh; Peter R Kowey; Rolf Wachter; Jonathan L Halperin; Rachelle E Kaplon; Erika Pouliot; Atul Verma
Journal:  J Atr Fibrillation       Date:  2017-02-28

Review 5.  Detection and management of atrial fibrillation after cryptogenic stroke or embolic stroke of undetermined source.

Authors:  Tommaso Sanna; Paul D Ziegler; Filippo Crea
Journal:  Clin Cardiol       Date:  2018-03-22       Impact factor: 2.882

6.  European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin.

Authors:  Marta Rubiera; Ana Aires; Kateryna Antonenko; Sabrina Lémeret; Christian H Nolte; Jukka Putaala; Renate B Schnabel; Anil M Tuladhar; David J Werring; Dena Zeraatkar; Maurizio Paciaroni
Journal:  Eur Stroke J       Date:  2022-06-03

Review 7.  Home Screening for Detecting Subclinical Atrial Fibrillation.

Authors:  Renato Pietro Ricci; Taya V Glotzer
Journal:  J Atr Fibrillation       Date:  2015-12-31

8.  Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.

Authors:  Steven J Edwards; Victoria Wakefield; Tracey Jhita; Kayleigh Kew; Peter Cain; Gemma Marceniuk
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

Review 9.  Atrial Cardiopathy and Stroke Prevention.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

Review 10.  Management of atrial high-rate episodes detected by cardiac implanted electronic devices.

Authors:  Ben Freedman; Giuseppe Boriani; Taya V Glotzer; Jeff S Healey; Paulus Kirchhof; Tatjana S Potpara
Journal:  Nat Rev Cardiol       Date:  2017-07-06       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.